Hemoglobin-based Oxygen Carrier (HBOC-201) and Escalating Doses of Recombinant Factor VIIa (rFVIIa) as a Novel Pre-hospital Resuscitation Fluid in a Swine Model of Severe Uncontrolled Hemorrhage

REFERENCES

• Butler, F. K., Jr., Holcomb, J. B., Giebner, S. D., McSwain, N. E., Bagian, J. (2007). Tactical combat casualty care 2007: evolving concepts and battlefield experience. Mil Med 172: 1–19.
   PubMed Web of Science ®Google Scholar
• Kelly, J. F. . (2008). Injury severity and causes of death from Operation Iraqi Freedom and Operation Enduring Freedom: 2003-2004 versus 2006. J Trauma 64: S21–26; discussion S26–27.
   PubMed Web of Science ®Google Scholar
• Gurney, J. . (2004). A hemoglobin based oxygen carrier, bovine polymerized hemoglobin (HBOC-201) versus Hetastarch (HEX) in an uncontrolled liver injury hemorrhagic shock swine model with delayed evacuation. J Trauma 57: 726–738.
   PubMedGoogle Scholar
• Katz, L. M. . (2002). HBOC-201 improves survival in a swine model of hemorrhagic shock and liver injury. Resuscitation 54: 77–87.
   PubMed Web of Science ®Google Scholar
• Manning, J. E. . (2000). Bovine hemoglobin-based oxygen carrier (HBOC-201) for resuscitation of uncontrolled, exsanguinating liver injury in swine. Carolina Resuscitation Research Group. Shock 13: 152–159.
   PubMed Web of Science ®Google Scholar
• Patel, M. B., Feinstein, A. J., Saenz, A. D., Majetschak, M., Proctor, K. G. (2006). Prehospital HBOC-201 after traumatic brain injury and hemorrhagic shock in swine. J Trauma 61: 46–56.
   PubMedGoogle Scholar
• Stern, S. . (2008). Resuscitation with the hemoglobin-based oxygen carrier, Hboc-201, in a swine model of severe uncontrolled hemorrhage and traumatic brain injury. Shock 2009 Jan 31(1): 64–79.
   Google Scholar
• Rosenthal, G. . (2008). Use of hemoglobin-based oxygen-carrying solution-201 to improve resuscitation parameters and prevent secondary brain injury in a swine model of traumatic brain injury and hemorrhage: laboratory investigation. J Neurosurg 108: 575–587.
   PubMed Web of Science ®Google Scholar
• Dudkiewicz, M., Harpaul, T. A., Proctor, K. G. (2008). Hemoglobin-based oxygen carrying compound-201 as salvage therapy for severe neuro- and polytrauma (Injury Severity Score = 27-41). Crit Care Med 36: 2838–2848.
   PubMedGoogle Scholar
• King, D. R., Cohn, S. M., Proctor, K. G. (2005). Resuscitation with a hemoglobin-based oxygen carrier after traumatic brain injury. J Trauma 59: 553–560; discussion 560–552.
   PubMedGoogle Scholar
• LaMuraglia, G. M. . (2000). The reduction of the allogenic transfusion requirement in aortic surgery with a hemoglobin-based solution. J Vasc Surg Feb 31(2): 299–308.
   PubMedGoogle Scholar
• Levy, J. H. (2003). The use of haemoglobin glutamer-250 (HBOC-201) as an oxygen bridge in patients with acute anaemia associated with surgical blood loss. Expert Opin Biol Ther 3: 509–517.
   PubMed Web of Science ®Google Scholar
• Levy, J. H. . (2002). Polymerized bovine hemoglobin solution as a replacement for allogeneic red blood cell transfusion after cardiac surgery: results of a randomized, double-blind trial. J Thorac Cardiovasc Surg Jul 124(1): 35–42.
   PubMed Web of Science ®Google Scholar
• Sprung, J. . (2002). The use of bovine hemoglobin glutamer-250 (Hemopure) in surgical patients: results of a multicenter, randomized, single-blinded trial. Anesth Analg Apr 94(4): 799–808.
   PubMed Web of Science ®Google Scholar
• Standl, T. . (1998). Bovine haemoglobin-based oxygen carrier for patients undergoing hemodilution before liver resection. Br J Anaesth Feb 80(2): 189–194 (1998).
   PubMedGoogle Scholar
• Brohi, K., Singh, J., Heron, M., Coats, T. (2003). Acute traumatic coagulopathy. J Trauma Jun 54(6): 1127–1130.
   PubMedGoogle Scholar
• MacLeod, J. B., Lynn, M., McKenney, M. G., Cohn, S. M., Murtha, M. (2003). Early coagulopathy predicts mortality in trauma. J Trauma 55: 39–44.
   PubMed Web of Science ®Google Scholar
• Borgman, M. A. . (2007). The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma 63: 805–813.
   PubMed Web of Science ®Google Scholar
• Rizoli, S. B. . (2006). Recombinant activated factor VII as an adjunctive therapy for bleeding control in severe trauma patients with coagulopathy: subgroup analysis from two randomized trials. Crit Care Dec 21; 10(6): R178 (2006).
   PubMedGoogle Scholar
• Monroe, D. M., Hoffman, M., Oliver J. A., Roberts, H. R. (1998). A possible mechanism of action of activated factor VII independent of tissue factor. Blood Coagul Fibrinolysis Suppl 1: S15–S20.
   Google Scholar
• Boffard, K. D. . (2005). Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma 59: 8–15; discussion 15–18.
   PubMed Web of Science ®Google Scholar
• Felfernig, M. (2007). Clinical experience with recombinant activated factor VII in a series of 45 trauma patients. J R Army Med Corps 153: 32–39.
   PubMedGoogle Scholar
• Geeraedts, L. M., Jr. . (2005). The role of recombinant factor VIIa in the treatment of life-threatening haemorrhage in blunt trauma. Injury 36: 495–500.
   PubMedGoogle Scholar
• Mayer, S. A. . (2006). Recombinant activated factor VII for acute intracerebral hemorrhage: US phase IIA trial. Neurocrit Care 4: 206–214.
   PubMed Web of Science ®Google Scholar
• Diringer, M. N. . (2008). Risk of thromboembolic events in controlled trials of rFVIIa in spontaneous intracerebral hemorrhage. Stroke 39: 850–856.
   PubMedGoogle Scholar
• Mayer, S. A. . (2008). Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 358: 2127–2137.
   PubMed Web of Science ®Google Scholar
• Arnaud, F. . (2008). Hematologic effects of recombinant factor VIIa combined with hemoglobin-based oxygen carrier-201 for prehospital resuscitation of swine with severe uncontrolled hemorrhage due to liver injury. Blood Coagul Fibrinolysis 19: 669–677.
   PubMed Web of Science ®Google Scholar
• Malkevich, N. V. . (2008). Innate immune response after resuscitation with hemoglobin-based oxygen carrier and recombinant factor VIIA in uncontrolled hemorrhagic shock in a swine model. J Trauma 64: 1498–1510.
   PubMedGoogle Scholar
• Moore, E. E. . (1995). Organ injury scaling: spleen and liver (1994 revision). J Trauma 38: 323–324.
   PubMed Web of Science ®Google Scholar
• Stein, D. M., Dutton, R. P., Kramer, M. E., Handley, C., Scalea, T. M. (2008). Recombinant factor VIIa: decreasing time to intervention in coagulopathic patients with severe traumatic brain injury. J Trauma 64: 620–627; discussion 627–628.
   PubMed Web of Science ®Google Scholar
• Stein, D. M., Dutton, R. P., O'Connor, J., Alexander, M., Scalea, T. M. (2005). Determinants of futility of administration of recombinant factor VIIa in trauma. J Trauma 59: 609–615.
   PubMedGoogle Scholar
• Zhang, J. . (2008). Hemostatic and neuroprotective effects of human recombinant activated factor VII therapy after traumatic brain injury in pigs. Exp Neurol 210: 645–655.
   PubMed Web of Science ®Google Scholar
• Ehrenreich, H., Bartels, C., Sargin, D., Stawicki, S., Krampe, H. (2008). Recombinant human erythropoietin in the treatment of human brain disease: focus on cognition. J Ren Nutr 18: 146–153.
   PubMedGoogle Scholar
• Owens, B. D. . (2008). Combat wounds in operation Iraqi Freedom and operation Enduring Freedom. J Trauma 64: 295–299.
   PubMed Web of Science ®Google Scholar
• Nedergaard, H. . (2008). In vitro stability of lyophilized and reconstituted recombinant activated factor VII formulated for storage at room temperature. Clin Ther 30: 1309–1315.
   PubMed Web of Science ®Google Scholar